With patent expiries and rising political pressure on drug pricing, the next two years could reshape who gets to benefit from this new era of metabolic medicine.For now, if you are curious about these drugs, talk to your clinician, check coverage options and weigh both the potential benefits and the long-term cost before deciding
Incumbents will defend with brand trust, real-world outcomes, rebate economics, patient programs, and next-gen pipelines, while entrants counter with cost leadership, domestic-first capture, and localized fill-finish to blunt rules-of-origin
Efficacy and safety of semaglutide 2.4 mg once weekly versus placebo for weight loss in patients with obesity: The STEP 1 trial
Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial
In addition, we applied flow cytometry to demonstrate that RT can be used for high-throughput quantification of GSH levels in single cells
The side effect profiles differ , but the injection technique does not